CFDE Data Portal | Search LINC02181

	Label	Description
	LINC02181 Gene (Entity type)	ENSG00000232190 - long intergenic non-protein coding RNA 2181
	GSE111247 temozolomide LN-308 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE203329 HCC knockout 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE200538 butyrolactone Hep-G2 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE183606 rutaecarpine 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx AdrenalGland 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx SmallIntestine 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx

LINC02181

ENSG00000232190 - long intergenic non-protein coding RNA 2181

GSE111247 temozolomide LN-308 0 v 8 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human up

A Gene Set from LINCS

GSE203329 HCC knockout 2 v 1 human up

A Gene Set from LINCS

GSE200538 butyrolactone Hep-G2 1 v 2 human dn

A Gene Set from LINCS

GSE230865 EYA2 knockdown 3 v 2 human dn

A Gene Set from LINCS

GSE183606 rutaecarpine 1 v 0 human up

A Gene Set from LINCS

GSE230865 EYA2 knockdown 1 v 0 human up

A Gene Set from LINCS

GTEx AdrenalGland 20-29 vs 40-49 Down

A Gene Set from GTEx

GTEx SmallIntestine 20-29 vs 40-49 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.